CDMO News
Syngene Upgrades High-Capacity Biologics Facility in India
Syngene International, a contract research, development and manufacturing organisation (CRDMO) has announced that its newly upgraded biologics facility ‘Unit 3’ would be operational for clinical and commercial supply in the second half of 2024. The facility will be available for
15 March 2024